Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1UB-312----[1] 6 💬
2UB-312 Injection----[2] 6, 17 💬
3Ubenimex[1] Ubenimex[1] Ubenimex 💬[1] ANPEP 💬[4] Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system 💬[1] 86 💬
4Ubidecarenon----[1] 5 💬
5Ubiquinol[1] Ubiquinol---[3] 6, 8, 17 💬
6UBLITUXIMAB[1] Ublituximab[1] Ublituximab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
7Ubltuximab----[1] 13 💬
8UC-MSC+DMARDS----[1] 46 💬
9UC-MSCs[1] Human Umbilical Cord Mesenchymal Stem Cells---[2] 46, 96 💬
10Ucb 34714----[2] 149, 309 💬
11Ucb L059----[1] 13 💬
12UCB0022----[1] 6 💬
13UCB0107 (bepranemab)----[1] 5 💬
14UCB0599----[1] 6 💬
15UCB3491----[1] 145 💬
16UCB4940----[3] 46, 97, 271 💬
17UCB5857----[1] 53 💬
18UCB7665----[3] 11, 14, 63 💬
19UCB7853----[1] 6 💬
20UCMSC----[2] 51, 94 💬
21UCMSC group----[1] 97 💬
22UDCA[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[6] 46, 67, 93, 94, 97, 296 💬
23UDCA (Ursodeoxycholic acid)[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
24Udenafil[1] Udenafil[1] Udenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 86, 210 💬
25UF-021----[1] 90 💬
26UF-021 (isopropyl unoprostone)[1] Unoprostone[1] Unoprostone 💬[1] PTGFR 💬[3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬[1] 90 💬
27UF-021(isopropyl unoprostone)[1] Unoprostone[1] Unoprostone 💬[1] PTGFR 💬[3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬[1] 90 💬
28UK 092480----[1] 86 💬
29UK-427,857----[1] 46 💬
30UK-92,480----[1] 86 💬
31UK-92,480-10----[1] 86 💬
32UK: Sativex Oromucosal Spray[2] Cannabidiol,
Dronabinol		[2] Dronabinol ,
Cannabidiol 💬		[2] CNR1,
CNR2 💬		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13 💬
33ULARITIDE[1] Ularitide---[1] 86 💬
34Ulipristal[1] Ulipristal[1] Ulipristal 💬[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 10 💬
35ULIPRISTAL ACETATE[2] Acetate,
Ulipristal		[1] Ulipristal 💬[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 10 💬
36Ultevursen----[2] 90, 303 💬
37Ultomiris[1] Ravulizumab[1] Ravulizumab 💬[1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[6] 2, 11, 13, 50, 62, 66 💬
38ULTOMIRIS - 300 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 3 ML (100 MG / ML) - 1 FLACONCINO[1] Ravulizumab[1] Ravulizumab 💬[1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
39Ultomiris 1,100 mg/11 mL[1] Ravulizumab[1] Ravulizumab 💬[1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11 💬
40Ultomiris 300 mg/30 ml[1] Ravulizumab[1] Ravulizumab 💬[1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 66 💬
41Ultomiris 300mg/30ml[1] Ravulizumab[1] Ravulizumab 💬[1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
42ULTOMIRIS ™ (ravulizumab-cwvz)[1] Ravulizumab[1] Ravulizumab 💬[1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
43ULTOMIRIS®[1] Ravulizumab[1] Ravulizumab 💬[1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 13 💬
44Ultra small particles of iron oxide (USPIO)[1] Ferric oxide[1] Ferric oxide 💬--[1] 13 💬
45Ultra-high-caloric carbohydrate-rich diet----[1] 2 💬
46Ultra-high-caloric fatty diet----[1] 2 💬
47Ultracet----[1] 271 💬
48Ultrase----[1] 299 💬
49Ultrase® MT12----[1] 299 💬
50Ultrase® MT20----[1] 299 💬
51Ultrasmall particles of iron oxide[1] Ferric oxide[1] Ferric oxide 💬--[1] 13 💬
52Ultrasound-guided Suprascapular Nerve Block----[1] 149 💬
53ULTRESA----[1] 299 💬
54Ultromiris----[1] 13 💬
55Umbilical Cord Based Allogenic Mesenchymal Stem Cell----[1] 113 💬
56Umbilical Cord Blood----[1] 60 💬
57Umbilical cord blood (UCB)----[1] 60 💬
58Umbilical Cord Blood After Myeloablative Conditioning----[1] 60 💬
59Umbilical Cord Blood After Reduced-Intensity Conditioning----[1] 60 💬
60Umbilical cord blood mononuclear cells----[1] 97 💬
61Umbilical Cord Blood Transplantation----[1] 60 💬
62Umbilical Cord Blood Unit----[1] 333 💬
63Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation----[2] 93, 296 💬
64Umbilical cord derived Mesenchymal Stem Cells----[1] 13 💬
65Umbilical Cord Lining Stem Cells----[1] 50 💬
66Umbilical Cord Mesenchymal Stem Cell----[1] 113 💬
67Umbilical Cord Mesenchymal Stem Cell (UC-MSC)----[1] 90 💬
68Umbilical cord mesenchymal stem cells----[5] 13, 46, 57, 97, 113 💬
69Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)[1] Human Umbilical Cord Mesenchymal Stem Cells---[1] 46 💬
70UN-ALPHA-R----[1] 235 💬
71UN-ALPHA-R 0.25µg----[1] 235 💬
72Unavailable----[1] 36 💬
73Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)[1] Genistein[1] Genistein 💬--[1] 299 💬
74Undecanoate[1] Undecanoic acid---[2] 13, 60 💬
75Undetermined----[1] 96 💬
76UNDIFFERENTIATED AUTOLOGOUS MESENCHYMAL STEM CELLS----[1] 13 💬
77Uniplas----[1] 64 💬
78Unknown----[3] 34, 67, 97 💬
79Unoprostone[1] Unoprostone[1] Unoprostone 💬[1] PTGFR 💬[3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬[1] 90 💬
80Unrelated BM with T cell depletion----[1] 65 💬
81Unrelated cord blood----[1] 65 💬
82Unrelated Umbilical Cord Blood Transplant----[1] 19 💬
83Untreated to atorvastatin treatment[1] Atorvastatin[1] Atorvastatin 💬[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 13 💬
84Upadacitinib[1] Upadacitinib[1] Upadacitinib 💬[1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[8] 40, 41, 46, 49, 96, 97, 107, 271 💬
85Upadacitinib (ABT-494)[1] Upadacitinib[1] Upadacitinib 💬[1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
86Upadacitinib - Direct compression-yellow[1] Upadacitinib[1] Upadacitinib 💬[1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
87Upadacitinib -Direct compression-yellow[1] Upadacitinib[1] Upadacitinib 💬[1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
88Upadacitinib 12mg[1] Upadacitinib[1] Upadacitinib 💬[1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
89Upadacitinib 15mg[1] Upadacitinib[1] Upadacitinib 💬[1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
90Upadacitinib 30mg[1] Upadacitinib[1] Upadacitinib 💬[1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
91Upadacitinib 3mg[1] Upadacitinib[1] Upadacitinib 💬[1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
92Upadaticitib----[1] 96 💬
93Updacitinib (ABT-494)----[1] 97 💬
94Uplizna[1] Inebilizumab[1] Inebilizumab 💬[1] CD19 💬[5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[2] 11, 300 💬
95UPLYSO----[1] 19 💬
96Uptravi[1] Selexipag[1] Selexipag 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[3] 84, 86, 88 💬
97UR-12746-S----[1] 97 💬
98Urate[1] Uric acid---[1] 6 💬
99Urbason----[3] 13, 97, 222 💬
100Urbason 40 mg----[1] 13 💬
101URBASON 40 mg comprimidos----[1] 13 💬
102URBASON FORTE----[1] 13 💬
103Urbason solubile forte 1000mg----[1] 13 💬
104URBASON*IM EV 1F 250MG+1F 5ML----[1] 222 💬
105Urbason® solubile forte 1000 mg----[1] 13 💬
106Urea[1] Urea[2] Urea ,
Urea C13 💬		--[2] 72, 251 💬
107URG101----[1] 226 💬
108Uridine[1] Uridine---[1] 299 💬
109Urinary levels of PIIINP as a marker of changes in renal function----[1] 299 💬
110Urine sample----[3] 49, 51, 61 💬
111Urine samples----[1] 13 💬
112Urine samples taken to measure methotrexate and its major metabolite 7-OH-methotrexate level[1] Methotrexate[1] Methotrexate 💬[2] DHFR,
DHFR2 💬		[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬[1] 46 💬
113Urodilatin----[1] 86 💬
114UROMITEXAN[1] Coenzyme M---[1] 85 💬
115Ursochol----[1] 67 💬
116URSOCHOL 300----[1] 67 💬
117Ursodeoxycholic acid[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[10] 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
118Ursodeoxycholic acid (UDCA)[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 94 💬
119Ursodeoxycholic acid (UDCA) 500 mg[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 46 💬
120Ursodeoxycholic Acid (URSO)[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
121Ursodeoxycholic Acid 300mg capsule[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
122Ursodeoxycholic Acid 300mg tablet[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
123Ursodeoxycholic Acid Capsules[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
124Ursodeoxycholic acid combination of immunosuppressive agents[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[2] 93, 95 💬
125Ursodeoxycholic acid combined with total glucosides of paeony[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
126Ursodeoxycholic acid only[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
127Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)[2] Methylprednisolone,
Ursodeoxycholic acid		[2] Methylprednisolone ,
Ursodiol 💬		[2] NR1H4,
NR3C1 💬		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 93 💬
128Ursodeoxycholsäure----[1] 93 💬
129Ursodiol[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[6] 8, 20, 93, 97, 234, 299 💬
130Ursodiol (ursodeoxycholic acid, UDCA)[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 97 💬
131Ursodoxicoltaurina----[1] 2 💬
132Ursodoxicoltaurine[1] Tauroursodeoxycholic acid[1] Taurursodiol 💬--[1] 2 💬
133Ursofalk[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[4] 93, 94, 96, 97 💬
134UrsoFalk® 250 mg tabletten.[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 96 💬
135Ursofalk® 500 mg film-coated tablets[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
136Ursofalk® 500 mg Filmtabletten[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
137Ursofalk® capsules[1] Ursodeoxycholic acid[1] Ursodiol 💬[1] NR1H4 💬[1] Bile secretion 💬[1] 93 💬
138Ursolic acid[1] Ursolic acid---[1] 94 💬
139Ursonorm----[1] 6 💬
140US guided ESPB----[1] 70 💬
141US TAP Bupivacaine/Epinephrine[2] Bupivacaine,
Epinephrine		[2] Epinephrine ,
Bupivacaine 💬		[14] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 96 💬
142US-licensed Humira®----[1] 46 💬
143USAN: sebelipasa alfa[1] Sebelipase alfa[1] Sebelipase alfa 💬[1] LIPA 💬[3] Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬[1] 19 💬
144USAN: sebelipase alpha----[1] 19 💬
145Use of lipid-lowering drugs.----[1] 265 💬
146UshStat----[2] 90, 303 💬
147UshStat (SAR421869)----[2] 90, 303 💬
148Ustekinumab[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
149Ustekinumab (approximately 6 mg/kg)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 49 💬
150Ustekinumab + MTX (Group 2)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 46 💬
151Ustekinumab + MTX (Group 3)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 46 💬
152Ustekinumab 130 mg IV[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
153Ustekinumab 180 mg[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 93 💬
154Ustekinumab 1mg/kg (IP)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
155Ustekinumab 3 mg/kg (IP)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
156Ustekinumab 4.5 mg/kg[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
157Ustekinumab 45 mg[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 93 💬
158Ustekinumab 6 mg/kg (IP)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
159Ustekinumab 90 mg[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[3] 49, 93, 96 💬
160Ustekinumab 90 mg (SC) Group 1[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
161Ustekinumab 90 mg (SC) Group 2[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
162Ustekinumab 90 mg SC q12w[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
163Ustekinumab 90 mg SC q8w[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
164Ustekinumab 90 milligram (mg)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 49 💬
165Ustekinumab approximately 6 mg/kg (IV)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
166Ustekinumab Dose Based on BSA and Body Weight[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 97 💬
167Ustekinumab induction[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 97 💬
168Ustekinumab Injection[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 160 💬
169Ustekinumab Injection [Stelara][1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
170Ustekinumab IV[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 49, 97 💬
171Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
172Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP)[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
173Ustekinumab liquid in prefilled syringe[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 84 💬
174Ustekinumab SC[1] Ustekinumab[1] Ustekinumab 💬[3] IL12A,
IL12B,
IL23A 💬		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 49, 97 💬
175Usual current care----[2] 96, 97 💬
176Usual dopaminergic per os treatment----[1] 6 💬
177UT-15 SR----[1] 51 💬
178UT-15C----[1] 86 💬
179UT-15C (treprostinil diethanolamine)[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
180UT-15C 0.25 mg----[1] 86 💬
181UT-15C 1 mg----[1] 86 💬
182UT-15C 5 mg----[1] 86 💬
183UT-15C LP----[1] 86 💬
184UT-15C SR----[2] 51, 86 💬
185UT-15C SR (treprostinil diethanolamine)[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
186UT-15C-SR----[2] 51, 86 💬
187Uterine----[1] 280 💬
188UTTR1147A----[2] 96, 97 💬
189UTTR1147A, IL22-Fc, IL-22Fc[1] Efmarodocokin alfa[1] Efmarodocokin alfa 💬[1] IL22 💬[4] Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬[2] 96, 97 💬
190UTTR1147A/RO7021610 (Active)----[2] 96, 97 💬
191UVADEX[1] Methoxsalen[1] Methoxsalen 💬--[3] 46, 51, 96 💬
192UVADEX and UVAR XTS Photopheresis System[1] Methoxsalen[1] Methoxsalen 💬--[1] 96 💬
193UVEDOSE----[1] 46 💬
194UVEDOSE 100 000 UI----[1] 13 💬
195UVEDOSE 100 000 UI, solution buvable en ampoule----[1] 13 💬
196UX001----[1] 30 💬
197UX003----[1] 19 💬
198UX007----[4] 8, 248, 256, 257 💬
199UX053----[1] 257 💬
200UX143, BPS804----[1] 274 💬
201UX701----[1] 171 💬
202UX701 (1.0 × 10^13 genome copies/kg)----[1] 171 💬
203UX701 (2.0 × 10^13 genome copies/kg)----[1] 171 💬
204UX701 (5.0 × 10^12 genome copies/kg)----[1] 171 💬